美国 · SEC FORM 4
ANAPTYSBIO, INC
ANAB · Nasdaq · CIK 0001370053 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
6 同一窗口内观察到的 Form 4 交易行
1 sales · 5 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-01-02 · EcoR1 Capital, LLC; NODELMAN OLEG.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -13.1%
- 3M
- -22.1%
- 6M
- +26.2%
- 12M
- —
波动率与流动性
- 波动率
- 62.7%
- Beta
- 0.41
- 平均每日成交额
- USD 27.9M
估值
- 市值
- USD 1.5B
- P/E
- —
基本面
- 利润率
- -5.6%
- ROE
- -35.6%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-03 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · 来自 Yahoo Finance：市值 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 5,236,151
- 上期报告
- 5,437,438
- 日均成交量
- 639,524
- 回补天数
- 8.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-01-02 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 6,646 | USD 12.95 | USD 86,066 | SEC 申报 ↗ |
| 2024-12-31 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 13,268 | USD 12.93 | USD 171,555 | SEC 申报 ↗ |
| 2024-12-30 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 65,184 | USD 12.92 | USD 842,177 | SEC 申报 ↗ |
| 2024-08-14 | EcoR1 Capital, LLC | 买入 (P) | Common Stock | 273,972 | USD 36.50 | USD 9,999,978 | SEC 申报 ↗ |
| 2022-05-05 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 668,237 | USD 21.63 | USD 14,453,966 | SEC 申报 ↗ |
| 2021-05-04 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 165,000 | USD 23.25 | USD 3,836,250 | SEC 申报 ↗ |
| 2021-05-03 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 20,800 | USD 23.31 | USD 484,848 | SEC 申报 ↗ |
| 2021-04-30 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 35,700 | USD 23.16 | USD 826,812 | SEC 申报 ↗ |
| 2021-04-27 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 33,800 | USD 23.82 | USD 805,116 | SEC 申报 ↗ |
| 2021-04-26 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 13,900 | USD 23.80 | USD 330,820 | SEC 申报 ↗ |
| 2021-04-23 | EcoR1 Capital, LLC; NODELMAN OLEG | 买入 (P) | Common Stock | 99,600 | USD 23.54 | USD 2,344,584 | SEC 申报 ↗ |
| 2021-03-09 | EcoR1 Capital, LLC | 买入 (P) | Common Stock | 531,000 | USD 18.70 | USD 9,929,700 | SEC 申报 ↗ |
| 2021-03-08 | EcoR1 Capital, LLC | 买入 (P) | Common Stock | 2,777,800 | USD 18.97 | USD 52,694,866 | SEC 申报 ↗ |
| 2021-02-23 | EcoR1 Capital, LLC | 买入 (P) | Common Stock | 29,500 | USD 25.48 | USD 751,660 | SEC 申报 ↗ |
Form 4 申报证据
67 transaction lines in the latest 365-day window; 211 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | RENTON HOLLINGS | 卖出 (S) | Common Stock | 5,000 | USD 49.87 | USD 249,372 | SEC 申报 ↗ |
| 2026-10-01 | RENTON HOLLINGS | 期权行权／转换 (M) | Common Stock | 5,000 | USD 18.03 | USD 90,150 | SEC 申报 ↗ |
| 2026-09-15 | Orwin John A | 期权行权／转换 (M) | Common Stock | 1,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | RENTON HOLLINGS | 卖出 (S) | Common Stock | 5,000 | USD 49.87 | USD 249,372 | SEC 申报 ↗ |
| 2026-10-01 | RENTON HOLLINGS | 期权行权／转换 (M) | Common Stock | 5,000 | USD 18.03 | USD 90,150 | SEC 申报 ↗ |
| 2026-09-15 | Orwin John A | 期权行权／转换 (M) | Common Stock | 1,300 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Schmid John P. | 期权行权／转换 (M) | Common Stock | 6,030 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | RENTON HOLLINGS | 期权行权／转换 (M) | Common Stock | 6,030 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Orwin John A | 期权行权／转换 (M) | Common Stock | 6,030 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-27 | Faga Daniel | 卖出 (S) | Common Stock | 17,679 | USD 61.61 | USD 1,089,222 | SEC 申报 ↗ |
| 2026-03-25 | Faga Daniel | 奖励／授予 (A) | Common Stock | 34,300 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-11 | LOUMEAU ERIC J | 卖出 (S) | Common Stock | 10,000 | USD 54.00 | USD 540,000 | SEC 申报 ↗ |
| 2026-02-11 | LOUMEAU ERIC J | 期权行权／转换 (M) | Common Stock | 10,000 | USD 29.70 | USD 297,000 | SEC 申报 ↗ |
| 2026-01-15 | Marquet Magda | 卖出 (S) | Common Stock | 11,000 | USD 48.23 | USD 530,568 | SEC 申报 ↗ |
| 2026-01-15 | Marquet Magda | 期权行权／转换 (M) | Common Stock | 11,000 | USD 26.11 | USD 287,210 | SEC 申报 ↗ |
| 2026-01-08 | MULROY DENNIS | 卖出 (S) | Common Stock | 2,515 | USD 44.71 | USD 112,446 | SEC 申报 ↗ |
| 2026-01-08 | Lizzul Paul F. | 卖出 (S) | Common Stock | 3,650 | USD 44.71 | USD 163,192 | SEC 申报 ↗ |
| 2026-01-08 | LOUMEAU ERIC J | 卖出 (S) | Common Stock | 2,210 | USD 44.71 | USD 98,809 | SEC 申报 ↗ |
| 2026-01-08 | Faga Daniel | 卖出 (S) | Common Stock | 14,281 | USD 44.71 | USD 638,504 | SEC 申报 ↗ |
| 2026-01-07 | MULROY DENNIS | 期权行权／转换 (M) | Common Stock | 6,700 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-07 | Lizzul Paul F. | 期权行权／转换 (M) | Common Stock | 8,525 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-07 | LOUMEAU ERIC J | 期权行权／转换 (M) | Common Stock | 5,888 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-07 | Faga Daniel | 期权行权／转换 (M) | Common Stock | 26,838 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-07 | MULROY DENNIS | 卖出 (S) | Common Stock | 1,908 | USD 45.11 | USD 86,070 | SEC 申报 ↗ |
| 2026-01-07 | Lizzul Paul F. | 卖出 (S) | Common Stock | 2,235 | USD 45.11 | USD 100,821 | SEC 申报 ↗ |
| 2026-01-07 | LOUMEAU ERIC J | 卖出 (S) | Common Stock | 9,639 | USD 45.56 | USD 439,179 | SEC 申报 ↗ |
| 2026-01-07 | Faga Daniel | 卖出 (S) | Common Stock | 9,202 | USD 45.11 | USD 415,102 | SEC 申报 ↗ |
| 2026-01-06 | MULROY DENNIS | 期权行权／转换 (M) | Common Stock | 5,245 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-06 | Lizzul Paul F. | 期权行权／转换 (M) | Common Stock | 6,145 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-06 | LOUMEAU ERIC J | 期权行权／转换 (M) | Common Stock | 5,545 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-06 | Faga Daniel | 期权行权／转换 (M) | Common Stock | 17,850 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-05 | MULROY DENNIS | 卖出 (S) | Common Stock | 3,363 | USD 43.26 | USD 145,483 | SEC 申报 ↗ |
| 2026-01-05 | Lizzul Paul F. | 卖出 (S) | Common Stock | 4,219 | USD 43.26 | USD 182,514 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ANAB |
| CIK | 0001370053 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 211 transaction lines from 2020-02-05 to 2026-10-01 14 P purchase lines · 89 S sale lines · 108 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.